Would someone really outlay $600k on two new machines if they think the company didn't have legs ?
That's the question that really tips me in favour of LBT coming good.
I wouldn't be approving that level of spending if I didn't think they would be around to provide support and upgrade paths in the future. It would just be a pointless tech dead end.
Combine that recent double sale with the upcoming Q3 MRSA FDA approval and US distribution deal and things are looking postive from where I sit.
I don't need multiple sales in the next month to come around.
The table has been set.
Looking forward to Q3.
GLTAH
5 months since good news, page-137
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(3.33%) |
Mkt cap ! $25.08M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.5¢ | $3.118K | 204.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2602938 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1568400 | 5 |
View Market Depth
| Last trade - 13.24pm 23/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |